BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25877876)

  • 1. Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.
    Lin DC; Xu L; Chen Y; Yan H; Hazawa M; Doan N; Said JW; Ding LW; Liu LZ; Yang H; Yu S; Kahn M; Yin D; Koeffler HP
    Cancer Res; 2015 May; 75(9):1815-27. PubMed ID: 25877876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin pathway activation mitigates glioma cell proliferation and predicts patient survival.
    Yeo CW; Ng FS; Chai C; Tan JM; Koh GR; Chong YK; Koh LW; Foong CS; Sandanaraj E; Holbrook JD; Ang BT; Takahashi R; Tang C; Lim KL
    Cancer Res; 2012 May; 72(10):2543-53. PubMed ID: 22431710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA Linc00320 inhibits glioma cell proliferation through restraining Wnt/β-catenin signaling.
    Tian S; Liu W; Pan Y; Zhan S
    Biochem Biophys Res Commun; 2019 Jan; 508(2):458-464. PubMed ID: 30503496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7.
    Pan SJ; Zhan SK; Ji WZ; Pan YX; Liu W; Li DY; Huang P; Zhang XX; Cao CY; Zhang J; Bian LG; Sun B; Sun QF
    Sci Rep; 2015 Jun; 5():11066. PubMed ID: 26067607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.
    Ma Q; Yang Y; Feng D; Zheng S; Meng R; Fa P; Zhao C; Liu H; Song R; Tao T; Yang L; Dai J; Wang S; Jiang WG; He J
    Oncotarget; 2015 Nov; 6(34):35851-65. PubMed ID: 26452219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.
    Zhu Y; Qiu Z; Zhang X; Qian F; Wang B; Wang L; Shi H; Yu R
    J Neurooncol; 2017 Jan; 131(1):31-39. PubMed ID: 27640199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of SCAI enhances glioma cell invasion and stem cell like phenotype by activating Wnt/β-catenin signaling.
    Chen X; Hu W; Xie B; Gao H; Xu C; Chen J
    Biochem Biophys Res Commun; 2014 May; 448(2):206-11. PubMed ID: 24785374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM45 functions as a tumor suppressor in the brain via its E3 ligase activity by stabilizing p53 through K63-linked ubiquitination.
    Zhang J; Zhang C; Cui J; Ou J; Han J; Qin Y; Zhi F; Wang RF
    Cell Death Dis; 2017 May; 8(5):e2831. PubMed ID: 28542145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of Tumor Suppressive Function of FBXO16 Ubiquitin Ligase Activates Wnt Signaling In Glioblastoma.
    Khan M; Muzumdar D; Shiras A
    Neoplasia; 2019 Jan; 21(1):106-116. PubMed ID: 30530053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WWC3 Inhibits Glioma Cell Proliferation Through Suppressing the Wnt/β-Catenin Signaling Pathway.
    Wang Y; Jiang M; Yao Y; Cai Z
    DNA Cell Biol; 2018 Jan; 37(1):31-37. PubMed ID: 29115863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An emerging role of PARK2 in cancer.
    Xu L; Lin DC; Yin D; Koeffler HP
    J Mol Med (Berl); 2014 Jan; 92(1):31-42. PubMed ID: 24297497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor.
    Jin Y; Cui D; Ren J; Wang K; Zeng T; Gao L
    Mol Carcinog; 2017 Mar; 56(3):945-959. PubMed ID: 27583705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARK2 promotes mitochondrial pathway of apoptosis and antimicrotubule drugs chemosensitivity
    Chen H; Li Y; Li Y; Chen Z; Xie L; Li W; Zhu Y; Xue H; Koeffler HP; Wu W; Hu K; Yin D
    Theranostics; 2020; 10(22):9984-10000. PubMed ID: 32929329
    [No Abstract]   [Full Text] [Related]  

  • 14. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc.
    Kim EJ; Kim SH; Jin X; Jin X; Kim H
    Cell Death Differ; 2017 Apr; 24(4):649-659. PubMed ID: 28060381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
    Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.
    Zhu Z; Liu Y; Li K; Liu J; Wang H; Sun B; Xiong Z; Jiang H; Zheng J; Hu Z
    Carcinogenesis; 2014 Aug; 35(8):1901-10. PubMed ID: 24876153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21.
    Dai B; Hu Z; Huang H; Zhu G; Xiao Z; Wan W; Zhang P; Jia W; Zhang L
    Biochem Biophys Res Commun; 2014 Nov; 454(1):221-7. PubMed ID: 25450384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor in lung cancer-1 (TSLC1) functions as a glioma tumor suppressor.
    Houshmandi SS; Surace EI; Zhang HB; Fuller GN; Gutmann DH
    Neurology; 2006 Nov; 67(10):1863-6. PubMed ID: 17130425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIB2 inhibits Wnt/β-Catenin/TCF4 signaling through its associated ubiquitin E3 ligases, β-TrCP, COP1 and Smurf1, in liver cancer cells.
    Xu S; Tong M; Huang J; Zhang Y; Qiao Y; Weng W; Liu W; Wang J; Sun F
    FEBS Lett; 2014 Nov; 588(23):4334-41. PubMed ID: 25311538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
    Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
    Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.